Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
Date:5/5/2009

share data) (Unaudited) Three Months Ended March 31, ------------- 2009 2008 ---- ---- Revenues $- $- -- -- Operating expenses: Research and development 8,104 6,336 General and administrative 3,084 4,183 Restructuring & asset impairment 1,056 - ----- - Total operating expenses 12,244 10,519 ------ ------ Loss from operations (12,244) (10,519) ------- ------- Other income (expense), net (706) 664 ---- --- Net loss (12,950) (9,855) Preferred stock dividends (125) (125) ---- ---- Loss applicable to common shares $(13,075) $(9,980) ======== ======= Loss per share: Basic and diluted $(0.38) $(0.29) ====== ====== Shares used in calculation of loss per share: Basic and diluted 34,688 34,681 ====== ====== Condensed Consolidated Balance Sheets (In thousands) (Unaudited) March 31, 2009 December 31, 2008
'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... COLORADO SPRINGS, Colo. , July 29, 2014 /PRNewswire-USNewswire/ ... remote-controlled catheter (MARC) which could allow physicians to see ... stroke may hold promise, according to study authors who ... Surgery (SNIS) 11 th Annual Meeting in ... findings stand to advance the field of neurointervention, a ...
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- MHG ... provider, has launched its Medical Equipment and ...  These services are tailored to the cruise industry,s ... prompted industry operators to propose that they should ... Medical,s new program is intended to create standardized ...
(Date:7/29/2014)... 29, 2014  Neurocrine Biosciences, Inc. (Nasdaq: ... its second quarter 2014 financial results after the Nasdaq ... then host a live conference call and webcast to ... Thursday morning, August 7, 2014 at 8:00 a.m. Eastern ... access the live conference call by dialing 866-952-1907 (US) ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Chlorine helps ... swimmers more likely to develop eye infections, doctors say. ... eyes as well as blurry vision, said Dr. Sampson ... Center in New Jersey. It,s important to understand ... pools washes away the outer film layer of the ...
(Date:7/29/2014)... Using quality improvement measures in eight of the ... Study Group, researchers have found a way to reduce ... dye. , Currently, 7-15 percent of these patients who ... with kidney injury, which can result in death or ... permanent dialysis, says a study published in the July ...
(Date:7/29/2014)... Historically, Memorial Day kicks off a three ... throughout that time by picnics, barbecues and beach outings. ... the start of a period that will witness a ... 2012 nearly 1.000 people were killed in crashes involving ... Labor Day. , The summer's warmer weather, longer days ...
(Date:7/29/2014)... Pendleton, SC (PRWEB) July 29, 2014 During ... Arthur L. Bruce, DMD & Associates, has had a steady ... more about dentistry. These students have now gone on to ... own practices, proving that the shadowing program helps college students ... school, Dr. Bruce has given them the chance to see ...
(Date:7/29/2014)... July 29, 2014 A team of ... Doug Ethell, PhD, has developed a blood test for ... and the development of Alzheimer’s disease interventions, according to ... is a puzzle, and this study represents one of ... over the past couple of years,” Ethell said. , ...
Breaking Medicine News(10 mins):Health News:Protect Your Eyes When Hitting the Pool 2Health News:Reducing kidney injury using a quality improvement method 2Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:Arthur Bruce Dental Helps College Students 2Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2
... ... , ... October 6, 2009 -- KelseyCare Advantage , a Houston-based Medicare Advantage plan serving ... Galveston on the Mainland, recently reported its Healthcare Effectiveness Data and Information Set (HEDIS) ...
... other dangers, but behavioral effects remain unclear, , TUESDAY, ... study to suggest an association between the plastics chemical ... report that BPA may affect the behavior of little ... displayed more "externalizing" behaviors, such as aggression and hyperactivity, ...
... SHANGHAI, China, Oct. 6 /PRNewswire-Asia-FirstCall/ -- ... leading Chinese firm,specializing in the manufacture, research, development, marketing ... team will attend the 2009 ROTH China Conference held ... The date, time and location of China-Biotics, presentation at ...
... found in red grapes, has been shown to improve ... little has been known about how these beneficial changes ... for publication in Endocrinology , a journal of ... key role in mediating resveratrol,s anti-diabetic actions, potentially paving ...
... ... Leading health and technology experts gathered recently at ... Health Technology SummitSM to explore advanced medical technologies being used to ... featured presentations was "Artificial Heart--Past, Current and Future," by Alexander Medvedev, ...
... ... Web Designs) is building and giving away 250 Free websites to the first ... so they have angered rivals and received a number of malicious phone calls ... they withdraw their offer to build these 250 free websites for small, local ...
Cached Medicine News:Health News:Local Medicare Advantage Plan Scores High on Diabetic Care and Blood Pressure Control 2Health News: Plastics Chemical Tied to Aggression in Young Girls 2Health News: Plastics Chemical Tied to Aggression in Young Girls 3Health News:China-Biotics, Inc. to Attend 2009 ROTH China Conference 2Health News:Future diabetes treatment may use resveratrol to target the brain 2Health News:Terumo Heart, Inc.'s DuraHeart™ Left-Ventricular Assist System Featured at Future of Health Technology Summit 2Health News:Terumo Heart, Inc.'s DuraHeart™ Left-Ventricular Assist System Featured at Future of Health Technology Summit 3Health News:SEO Consultant Top Rank Web Designs Gives Away 250 Free Websites 2Health News:SEO Consultant Top Rank Web Designs Gives Away 250 Free Websites 3Health News:SEO Consultant Top Rank Web Designs Gives Away 250 Free Websites 4
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Smith & Nephew offers a wide variety of cannulated screw products. Most screw sizes are available in both partially threaded and fully threaded versions. , ,All systems optimize implant strength with...
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
... Retrograde Humeral Nail enables fixation of humeral ... that may be associated with antegrade nailing. ... and distal interlocking using a nail-mounted targeting ... interlocking with the patient in the prone ...
Medicine Products: